DexCom, Inc. (NASDAQ:DXCM) Shares Purchased by Fifth Third Bancorp
Fifth Third Bancorp grew its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 21.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm ...
drugdeliverybusiness4 天
Dexcom CEO says 2025 is ‘shaping up to be a good year’ with Stelo launch, GenAI integration
Notably, Dexcom continues to innovate, with a future iteration of its CGM on the way. Sayer described the next-generation ...
verywellhealth4 天
What to Know About Continuous Glucose Monitoring
Continuous glucose monitoring (CGM) devices provide real-time blood sugar readings 24 hours a day, allowing people with type 1 or type 2 diabetes to closely track blood glucose levels and trends. Most ...
pharmaphorum1 天
FDA clears first OTC glucose biosensor, from Dexcom
The FDA has cleared Dexcom’s Stelo as the first continuous glucose monitoring (CGM) device that does not need a prescription, which can be used by diabetics on oral medications, as well as non ...
Yahoo Finance4 天
DexCom, Inc. (DXCM)
After hours: 7:59:25 pm GMT-5 ...
Forbes3 天
5 Key Insights On Dexcom’s Stelo & Abbott’s Lingo Glucose Monitors
In March 2024, the Food and Drug Administration (FDA) cleared Dexcom’s Stelo as the ... despite the conceptual benefits of using continuous glucose monitoring for optimizing exercise, there ...
Nature2 天
Diabetes Management and Continuous Glucose Monitoring
Additionally, the accuracy and safety of the latest CGM devices, such as the Dexcom G7, have been validated, showing high agreement rates with laboratory glucose measurements [5]. This reliability ...